Subunit vaccine containing particle carriers and application of subunit vaccine
A subunit vaccine and carrier technology, applied to medical preparations containing active ingredients, antibody medical ingredients, viruses/bacteriophages, etc., can solve problems such as complex production process, high R&D cost, and long R&D cycle, and avoid aggregation and precipitation , reduce R&D costs, and simplify the production process
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0042] The preparation of embodiment 1 nano virus-like particle novel coronavirus COVID-19 vaccine
[0043] This example is a preparation of a novel coronavirus COVID-19 vaccine based on protein self-assembly controllable nano-virus-like particles. Among them, the antigenic protein is selected from the novel coronavirus SARS-CoV-2 RBD-SD1 protein, and the antigenic protein is connected with a polypeptide linker and a silica binding peptide. Among them, the role of the linker is to connect the binding peptide and the antigenic protein, and the role of the silica-binding peptide is to increase the specific binding force between the antigenic protein and the silica nanoparticles. The expression system is mammalian cells. The antigenic protein connected to the linker and the binding peptide is assembled into a virus-like COVID-19 vaccine by combining with silica nanoparticles with a particle size of 20nm. The principle is as follows figure 2 shown
[0044] Polyclonal antibodie...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 



